Viewing Study NCT02741622



Ignite Creation Date: 2024-05-06 @ 8:28 AM
Last Modification Date: 2024-10-26 @ 12:00 PM
Study NCT ID: NCT02741622
Status: COMPLETED
Last Update Posted: 2018-12-04
First Post: 2016-03-15

Brief Title: Brain Derived Neurotropic Factor Response to Aerobic Exercise Intensity in Depressive Patients
Sponsor: St Olavs Hospital
Organization: St Olavs Hospital

Study Overview

Official Title: Effects of Aerobic Exercise Intensity on Affective States and Brain Derived Neurotropic Factor in Patients With Depression
Status: COMPLETED
Status Verified Date: 2018-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Acute aerobic exercise improves affective stats in patients with mental illnesses Brain derived neurotropic factor BDNF may be a biological mechanism that contributes to the affective benefits The magnitude of the increase of serum BDNF might be exercise intensity dependent but no study has compared low high-aerobic-intensity training at 90-95 of the maximal heart rate HRmax with long-slow-distance training at 70 of the HRmax in patients with depression

The aim of this study is to compare changes in serum BDNF levels after high-aerobic-intensity training and long-slow-distance training in a intra-individual design in patients suffering from depression The results will give indications of a possible difference in BDNF response between aerobic intensities and may be uses as pilot data for calculating sample size
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None